Snus: Difference between revisions
Jump to navigation
Jump to search
Richardpruen (talk | contribs) (→Studies: added suggested study and info to section) |
Richardpruen (talk | contribs) (→Studies: Added study found on twitter group) |
||
| Line 43: | Line 43: | ||
=== Studies === | === Studies === | ||
'''2022:''' [https://onlinelibrary.wiley.com/doi/10.1111/eos.12885 The effect of a non-tobacco-based nicotine pouch on mucosal lesions caused by Swedish smokeless tobacco (snus)] (Sara Alizadehgharib, Anna Lehrkinder, Ali Alshabeeb, Anna-Karin Östberg, Peter Lingström) | |||
"Oral mucosal lesions are commonly found in Swedish smokeless tobacco (snus) users where the pouch is placed. These lesions are reversible, that is, clinical and histological tissue changes return to normal following cessation." | |||
"The main aim of this study was to investigate how the oral mucosa was affected if users substituted their regular Swedish snus with non-tobacco-based nicotine products (investigational products)." | |||
"Because of these circumstances, the extent to which the use of the investigational non-tobacco-based nicotine pouch may cause mucosal lesions similar to those produced by regular, tobacco-based snus is unclear. " | |||
'''2022:''' [https://pubmed.ncbi.nlm.nih.gov/35840660/ Swedish snuff (snus) dipping, cigarette smoking, and risk of peripheral artery disease: a prospective cohort study] (Shuai Yuan, Olga E Titova, Scott M Damrauer, Agneta Åkesson, Susanna C Larsson) | '''2022:''' [https://pubmed.ncbi.nlm.nih.gov/35840660/ Swedish snuff (snus) dipping, cigarette smoking, and risk of peripheral artery disease: a prospective cohort study] (Shuai Yuan, Olga E Titova, Scott M Damrauer, Agneta Åkesson, Susanna C Larsson) | ||